Post-Transplantation Early Blood Transfusion And Kidney Allograft Outcomes: A Single-Center Observational Study

The association between blood transfusion and the occurrence of HLA donor specific antibodies (DSA) after kidney transplantation remains controversial. In this single-center observational study, we examined the association between early blood transfusion, i.e. before 1-month post-transplantation, and the risk of DSA occurrence, using Luminex based-methods. In total, 1,424 patients with a minimum of 1-month follow-up were evaluated between January 2007 and December 2018. During a median time of follow-up of 4.52 years, we observed 258 recipients who had at least one blood transfusion during the first month post-transplantation. At baseline, recipients in the transfused group were significant older, more sensitized against HLA class I and class II antibodies and had a higher 1-month serum creatinine. Cox proportional hazards regression analyses did not show any significant association between blood transfusion and the risk of DSA occurrence (1.35 [0.86-2.11], = 0.19), the risk of rejection (HR = 1.33 [0.94-1.89], = 0.11), or the risk of graft loss (HR = 1.04 [0.73-1.50], = 0.82). These data suggest then that blood transfusion may not be limited when required in the early phase of transplantation, and may not impact long-term outcomes.